OpenVSafe by OpenVAERS
Search V-safe

5RF-16253-15401

3 vaccinations 7 coded responses 40 check-ins 7 free-text entries 0 call cases
Sex
Male
Age at first dose
36-40
ZIP prefix
021 / MA
Registered
2021-01-12
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-12
    Registered in v-safe
  2. 2021-01-12
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-12
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  4. 2021-01-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-19
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-26
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-01
    Dose 2 — Pfizer-BioNTech
  13. 2021-02-01
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-02-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Fatigue or tiredness
    Adult check-in
  15. 2021-02-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: Induration, Lymph node pain, Lymphadenopathy — Feeling: Good · Muscle or body aches
    Free text: Notable and visible lymph node swelling at the clavicle and armpit area on the same arm as the injection site. Nodes firm, painful at touch, less painful at rest, and can be visualized
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-02-04
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Muscle or body aches
    Free text: Continued lymph node enlargement on clavicle and arm pit
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-05
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Muscle or body aches
    Free text: Continued lymph node swelling clavicle area and arm pit
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-02-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-02-08
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-02-15
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-22
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-01
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-08
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-03-15
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  26. 2021-05-03
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-08-02
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-10-02
    Dose 3 — Pfizer-BioNTech
  29. 2021-10-02
    Health check-in — day 0, dose 3
    Feeling: Good · None
    Adult check-in
  30. 2021-10-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Chills
    Adult check-in
  31. 2021-10-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  32. 2021-10-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  33. 2021-10-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-10-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-10-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  36. 2021-10-09
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  37. 2021-10-18
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-10-24
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  39. 2021-10-30
    Survey response — day 28, dose 3
    MedDRA: Fatigue, Nasopharyngitis, Oropharyngeal pain, Pain, Rhinorrhoea — Feeling: Fair
    Free text: Common cold symptoms. Runny nose, sore throat, body aches, fatigue
    MedDRA releases: 2024-11 · check-in free text available
  40. 2021-11-06
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  41. 2021-11-15
    Survey response — day 42, dose 3
    MedDRA: Cough, Fatigue, Respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Congestion, persistent cough, fatigue
    MedDRA releases: 2024-11 · check-in free text available
  42. 2022-01-01
    Survey response — 3 months, dose 3
    MedDRA: COVID-19, Chest discomfort, Chills, Cough, Pain — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Body aches, chills, cough, chest heaviness, postive Covid-19
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-04-02
    Survey response — 6 months, dose 3
    MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Had COVID
    MedDRA releases: 2024-11 · check-in free text available
  44. 2022-10-02
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-12Pfizer-BioNTech
22021-02-01Pfizer-BioNTech
32021-10-02Pfizer-BioNTech No

Free text

Release 3 — days 1–6 daily, dose 2

2021-02-03

Systemic reaction (other): Notable and visible lymph node swelling at the clavicle and armpit area on the same arm as the injection site. Nodes firm, painful at touch, less painful at rest, and can be visualized

2021-02-04

Systemic reaction (other): Continued lymph node enlargement on clavicle and arm pit

2021-02-05

Systemic reaction (other): Continued lymph node swelling clavicle area and arm pit

Release 10 — day 28, dose 3

2021-10-30

Symptoms: Common cold symptoms. Runny nose, sore throat, body aches, fatigue

Release 10 — day 42, dose 3

2021-11-15

Symptoms: Congestion, persistent cough, fatigue

Release 10 — 3 months, dose 3

2022-01-01

Symptoms: Body aches, chills, cough, chest heaviness, postive Covid-19

Release 11 — 6 months, dose 3

2022-04-02

Symptoms: Had COVID

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDChest discomfort · · ✓
SDChills · · ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDFatigue · · ✓
SDNasopharyngitis · · ✓
SDOropharyngeal pain · · ✓
SDPain · · ✓
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓
SROInduration ✓ ✓ ✓
SROLymph node pain ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…